Canvert-M
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Canvert-M, covering 2025-07-30 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks [Phase 4]